| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.13 | 0.7 |